Gemfibrozil increases the specific binding of rat-cortex nuclear extracts to a PPRE probe

Life Sciences

Volumn 73, Issue 23, 2003, Pages 2927-2937

  Sanguino, Elena ^a   Ramón, Miguel ^a   Roglans, Núria ^a   Alegret, Marta ^a   Sánchez, Rosa M ^a   Vázquez Carrera, Manuel ^a   Laguna, Juan C ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

ACO; Fibrates; Gemfibrozil; PPAR; Rat cortex

Indexed keywords

ACYL COENZYME A OXIDASE; BRAIN ENZYME; CELL EXTRACT; GEMFIBROZIL; MESSENGER RNA; OLIGONUCLEOTIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; BRAIN NUCLEUS; BRAIN TISSUE; CONTROLLED STUDY; DRUG EFFECT; DRUG TISSUE LEVEL; HYPOLIPEMIA; LIVER; MALE; NONHUMAN; RAT;

EID: 0141756332     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2003.04.001     Document Type: Article

References (28)

1. Alegret M., Ferrando R., Vázquez M., Adzet T., Merlos M., Laguna J.C. Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates. British Journal of Pharmacology. 112:1994;551-556.
2. Basu-Modak S., Braissant O., Escher P., Desvergne B., Honegger P., Wahli W. Peroxisome proliferator-activated receptor β regulates acyl-CoA synthetase 2 in reaggregated rat brain cell cultures. Journal of Biological Chemistry. 274:1999;35881-35888.
3. Berthou L., Saladin R., Yaqoob P., Branellec D., Calder P., Fruchart J.-C., Denèfle P., Auwerx J., Staels B. Regulation of rat liver apolipoprotein A-I, apolipoprotein A-II and acyl-coenzyme A oxidase gene by fibrates and dietary fatty acids. European Journal of Biochemistry. 232:1995;178-187.
4. Bradford M. A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
5. Cabrero A., Laguna J.C., Vázquez M. Peroxisome proliferator-activated receptors and the control of inflammation. Current Drug Targets in Inflammation and Alergy. 1:2002;243-248.
6. Cayen M.N. Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man. Pharmacology and Therapeutics. 29:1985;157-204.
7. Combs C.K., Bates P., Colleen Karlo J., Landreth G.E. Regulation of β-amyloid stimulated proinflammatory responses by peroxisome proliferator-activated receptor α Neurochemistry International. 39:2001;449-457.
8. Combs C.K., Johnson D.E., Colleen Karlo J., Cannady S.B., Landreth G.E. Inflammatory mechanisms in Alzheimer's disease: Inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. Journal of Neuroscience. 20:2000;558-567.
9. Cullingford T.E., Bhakoo K., Peuchen S., Dolphin C.T., Patel R., Clark J.B. Distribution of mRNAs encoding the peroxisome proliferator-activated receptor α, β and γ and the retinoid X receptor α, β and γ in rat central nervous system. Journal of Neurochemistry. 70:1998;1366-1375.
10. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acid Research. 11:1983;1475-1489.
11. Freeman W.M., Walker S.J., Vrana E.V. Quantitative RT-PCR: Pitfalls and potential. Biological Tecniques. 26:1999;112-125.
12. Jow L., Mukherjee R. The human peroxisome proliferator-activated receptor (PPAR) subtype NUC1 represses the activation of hPPARα and thyroid hormone receptors. Journal of Biological Chemistry. 270:1995;3836-3840.
13. Keller J.M., Collet P., Bianchi A., Huin C., Bouillaud-Kremarik P., Becuwe P., Schohn H., Domenjoud L., Dauça M. Implications of peroxisome proliferator-activated receptors (PPARs) in development, cell life status and disease. International Journal of Developmental Biology. 44:2000;429-442.
14. Kersten S., Desvergne B., Wahli W. Roles of PPARs in health and disease. Nature. 405:2000;421-424.
15. Kitamura Y., Shimohama S., Koike H., Kakimura J.-i., Matsuoka Y., Nomura Y., Gebicke-Haerter P.J., Taniguchi T. Increased expression of cyclooxygenases and peroxisome proliferator-activated receptor-γ in Alzheimer's disease brain. Biochemical Biophysical Research Communications. 254:1999;582-586.
16. Knoll A., Salles J., Sargueil F., Cassagne C., Garbay B. Peroxisomal beta-oxidation enzyme gene expression in the developing mouse brain. Neuroscience Letters. 285:2000;201-204.
17. Krey G., Braissant O., L'Horset F., Kalkhoben E., Perroud M., Parker M.G., Wahli W. Fatty acids, eicosanoids and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by CARLA. Molecular Endocrinology. 11:1997;779-791.
18. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammatory drugs. Journal of Biological Chemistry. 272:1997;3406-3410.
19. McGreer E.G., McGreer P.L. Brain inflammation in Alzheimer disease and the therapeutic implications. Current Pharmaceutical Design. 5:1999;821-836.
20. McGreer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology. 47:1996;425-432.
21. Mochizuki K., Suruga K., Yagi E., Takase S., Goda T. The expression of PPAR-associated genes is modulated through postnatal development of PPAR subtypes in the small intestine. Biochimica Biophysica Acta. 1531:2001;68-76.
22. Montgomery M.R., Cinti D.L. Pyridine nucleotide-dependent electron transport in kidney cortex microsomes: interaction between desaturase and other mixed function oxidases. Molecular Pharmacology. 13:1977;60-69.
23. Rodríguez C., Noé V., Cabrero A., Ciudad C.J., Laguna J.C. Differences in the formation of PPARα-RXR/acoPPRE complexes between responsive and nonresponsive species upon fibrate administration. Molecular Pharmacology. 58:2000;185-193.
24. Saluja I., Granneman J.G., Skoff R.P. PPARδ agonists stimulate oligodendrocyte differentiation in tissue culture. Glia. 33:2001;191-204.
25. Shi Y., Hon M., Evans R.M. The peroxisome proliferator-activated receptor δ, an integrator of transcriptional repression and nuclear receptor signaling. Proceedings of the National Academy of Sciences USA. 99:2002;2613-2618.
26. Sonnenberg J.L., MacGregor-Leon P.F., Curran T., Morgan J.I. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizures. Neuron. 3:1989;359-365.
27. Spencer C.M., Barradell L.B. Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidemia. Drugs. 51:1996;982-1018.
28. Todd P.A., Ward A. Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use un dyslipidemia. Drugs. 36:1988;314-339.